95 related articles for article (PubMed ID: 29565482)
1. The expression of TP53 pathway-related proteins in ovarian carcinoma transplanted subcutaneously in nude mice.
Zhang SR; Li DB; Xue JW
Eur Rev Med Pharmacol Sci; 2018 Mar; 22(5):1258-1264. PubMed ID: 29565482
[TBL] [Abstract][Full Text] [Related]
2. Discriminating functional and non-functional p53 in human tumours by p53 and MDM2 immunohistochemistry.
Nenutil R; Smardova J; Pavlova S; Hanzelkova Z; Muller P; Fabian P; Hrstka R; Janotova P; Radina M; Lane DP; Coates PJ; Vojtesek B
J Pathol; 2005 Nov; 207(3):251-9. PubMed ID: 16161005
[TBL] [Abstract][Full Text] [Related]
3. MDM2 is a potential therapeutic target and prognostic factor for ovarian clear cell carcinomas with wild type TP53.
Makii C; Oda K; Ikeda Y; Sone K; Hasegawa K; Uehara Y; Nishijima A; Asada K; Koso T; Fukuda T; Inaba K; Oki S; Machino H; Kojima M; Kashiyama T; Mori-Uchino M; Arimoto T; Wada-Hiraike O; Kawana K; Yano T; Fujiwara K; Aburatani H; Osuga Y; Fujii T
Oncotarget; 2016 Nov; 7(46):75328-75338. PubMed ID: 27659536
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of SCYL1-BP1 stabilizes functional p53 by suppressing MDM2-mediated ubiquitination.
Yan J; Di Y; Shi H; Rao H; Huo K
FEBS Lett; 2010 Oct; 584(20):4319-24. PubMed ID: 20849854
[TBL] [Abstract][Full Text] [Related]
5. Misregulation of polo-like protein kinase 1, P53 and P21WAF1 in epithelial ovarian cancer suggests poor prognosis.
Zhang R; Shi H; Ren F; Liu H; Zhang M; Deng Y; Li X
Oncol Rep; 2015 Mar; 33(3):1235-42. PubMed ID: 25592872
[TBL] [Abstract][Full Text] [Related]
6. Murine double minute 2 siRNA and wild-type p53 gene therapy interact positively with zinc on prostate tumours in vitro and in vivo.
Gu J; Wang B; Liu Y; Zhong L; Tang Y; Guo H; Jiang T; Wang L; Li Y; Cai L
Eur J Cancer; 2014 Apr; 50(6):1184-94. PubMed ID: 24447832
[TBL] [Abstract][Full Text] [Related]
7. Co-transduction of ribosomal protein L23 enhances the therapeutic efficacy of adenoviral-mediated p53 gene transfer in human gastric cancer.
Zhang YF; Zhang BC; Zhang AR; Wu TT; Liu J; Yu LF; Wang WX; Gao JF; Fang DC; Rao ZG
Oncol Rep; 2013 Oct; 30(4):1989-95. PubMed ID: 23933826
[TBL] [Abstract][Full Text] [Related]
8. An inhibitory effect on cell proliferation by blockage of the MAPK/estrogen receptor/MDM2 signal pathway in gynecologic cancer.
Suga S; Kato K; Ohgami T; Yamayoshi A; Adachi S; Asanoma K; Yamaguchi S; Arima T; Kinoshita K; Wake N
Gynecol Oncol; 2007 May; 105(2):341-50. PubMed ID: 17306348
[TBL] [Abstract][Full Text] [Related]
9. Association of Molecular Genetic Markers of TP53, MDM2, and CDKN1A Genes with Progression-Free Survival of Patients with Ovarian Cancer after Platinum-Based Chemotherapy.
Zavarykina TM; Tyulyandina AS; Khokhlova SV; Khabas GN; Asaturova AV; Nosova YA; Brenner PK; Kapralova MA; Atkarskaya MV; Khodyrev DS; Burdennyi AM; Loginov VI; Stenina MB; Sukhikh GT
Bull Exp Biol Med; 2020 Aug; 169(4):486-490. PubMed ID: 32910383
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-17 promotes normal ovarian cancer cells to cancer stem cells development via suppression of the LKB1-p53-p21/WAF1 pathway.
Liu T; Qin W; Hou L; Huang Y
Tumour Biol; 2015 Mar; 36(3):1881-93. PubMed ID: 25510663
[TBL] [Abstract][Full Text] [Related]
11. CALB1 enhances the interaction between p53 and MDM2, and inhibits the senescence of ovarian cancer cells.
Cao LQ; Wang YN; Liang M; Pan MZ
Mol Med Rep; 2019 Jun; 19(6):5097-5104. PubMed ID: 31059057
[TBL] [Abstract][Full Text] [Related]
12. RT-PCR amplification of RNA extracted from formalin-fixed, paraffin-embedded oral cancer sections: analysis of p53 pathway.
Tachibana M; Shinagawa Y; Kawamata H; Omotehara F; Horiuchi H; Ohkura Y; Kubota K; Imai Y; Fujibayashi T; Fujimori T
Anticancer Res; 2003; 23(3C):2891-6. PubMed ID: 12926130
[TBL] [Abstract][Full Text] [Related]
13. Mdm2, p53, p21 and pAKT protein pathways in benign neoplasms of the salivary gland.
Marques YM; de Lima Mde D; de Melo Alves Sde M; Soares FA; de Araújo VC; Pinto Ddos S; Mantesso A
Oral Oncol; 2008 Sep; 44(9):903-8. PubMed ID: 18485798
[TBL] [Abstract][Full Text] [Related]
14. Regulation of p53 and suppression of apoptosis by the soluble guanylyl cyclase/cGMP pathway in human ovarian cancer cells.
Fraser M; Chan SL; Chan SS; Fiscus RR; Tsang BK
Oncogene; 2006 Apr; 25(15):2203-12. PubMed ID: 16288207
[TBL] [Abstract][Full Text] [Related]
15. Intracellular CD24 disrupts the ARF-NPM interaction and enables mutational and viral oncogene-mediated p53 inactivation.
Wang L; Liu R; Ye P; Wong C; Chen GY; Zhou P; Sakabe K; Zheng X; Wu W; Zhang P; Jiang T; Bassetti MF; Jube S; Sun Y; Zhang Y; Zheng P; Liu Y
Nat Commun; 2015 Jan; 6():5909. PubMed ID: 25600590
[TBL] [Abstract][Full Text] [Related]
16. A novel apoptotic mechanism of genetically engineered adenovirus-mediated tumour-specific p53 overexpression through E1A-dependent p21 and MDM2 suppression.
Yamasaki Y; Tazawa H; Hashimoto Y; Kojima T; Kuroda S; Yano S; Yoshida R; Uno F; Mizuguchi H; Ohtsuru A; Urata Y; Kagawa S; Fujiwara T
Eur J Cancer; 2012 Sep; 48(14):2282-91. PubMed ID: 22244827
[TBL] [Abstract][Full Text] [Related]
17. [Expression and clinical significance of P53 pathway-associated proteins in pancreatic carcinoma].
Yu GZ; Zhu MH; Chen Y; Ni CR; Li FM
Ai Zheng; 2005 Nov; 24(11):1398-403. PubMed ID: 16552971
[TBL] [Abstract][Full Text] [Related]
18. Antisense anti-MDM2 oligonucleotides as a novel therapeutic approach to human breast cancer: in vitro and in vivo activities and mechanisms.
Wang H; Nan L; Yu D; Agrawal S; Zhang R
Clin Cancer Res; 2001 Nov; 7(11):3613-24. PubMed ID: 11705884
[TBL] [Abstract][Full Text] [Related]
19. [Expression of Jagged1 mRNA in human epithelial ovarian carcinoma tissues and effect of RNA interference of Jagged1 on growth of xenograft in nude mice].
Liu GY; Gao ZH; Li L; Song TT; Sheng XG
Zhonghua Fu Chan Ke Za Zhi; 2016 Jun; 51(6):448-53. PubMed ID: 27356481
[TBL] [Abstract][Full Text] [Related]
20. Nitidine chloride induces apoptosis in human hepatocellular carcinoma cells through a pathway involving p53, p21, Bax and Bcl-2.
Ou X; Lu Y; Liao L; Li D; Liu L; Liu H; Xu H
Oncol Rep; 2015 Mar; 33(3):1264-74. PubMed ID: 25530218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]